May 10, 2024
https://blogs.oncolink.org/2021/02/rare-disease-day-raising-awareness-for-rare-cancers/

Yearly on the final day of February, the world acknowledges uncommon illnesses—a day now often called Rare Disease Day. Uncommon illnesses have an effect on roughly 25 million to 30 million individuals in the US annually. The aim of Uncommon Illness Day is to teach the general public and lift consciousness amongst decision-makers in regards to the impression of uncommon illnesses on sufferers’ lives. Resolution-makers embody those that make strides advancing vital analysis: policymakers, trade representatives, well being professionals, advocates, and extra. By way of their help, extra motion will be taken to fight uncommon illnesses.

In line with the National Cancer Institute (NCI), about one-quarter of all most cancers deaths annually are brought on by uncommon cancers. And, in actual fact, most sorts of most cancers are thought-about uncommon. Sadly, uncommon cancers are tougher to deal with than widespread cancers—and they’re harder to analysis due to the restricted variety of sufferers. Different points associated to uncommon cancers embody lack of awareness amongst physicians about uncommon cancers, and issue discovering specialists who can reply questions.

Regardless of these obstacles, researchers do discover methods to check uncommon cancers and develop higher prevention methods and coverings. For instance, in June 2020 the results of the primary randomized medical trial for inoperable anal most cancers decided the perfect chemotherapy routine for sufferers. Earlier than the trial, the standard strategy for these sufferers was palliative care or care that focuses on offering aid from ache and different signs. Now, researchers are constructing on their findings in a phase III clinical trial that can add an immunotherapy drug to chemotherapy to hopefully enhance affected person care even additional.

A medical trial could also be a good selection for somebody identified with a uncommon most cancers, although sufferers ought to all the time talk about remedy choices with their physician first. Details about most cancers medical trials is offered in OncoLink’s Clinical Trials section, which additionally features a useful clinical trial matching service. Examples of uncommon most cancers medical trials which can be presently accessible embody:

  • Neuroendocrine tumors (NETs)
  • Penile most cancers
  • Mantle cell lymphoma

In the US, NETs happen in about 12,000 individuals annually; these tumors can seem in any a part of the physique, however typically develop within the lungs, gastrointestinal tract, or pancreas. Mantle cell lymphoma, a uncommon sort of non-Hodgkin lymphoma, impacts about 4,200 individuals yearly whereas penile most cancers impacts simply 2,200 individuals annually. With a purpose to be thought-about “uncommon,” a most cancers can solely happen in 40,000 individuals or fewer per 12 months within the US. Nevertheless, when taken collectively, uncommon cancers are literally extra widespread than breast, colon, lung, or prostate most cancers. And, individuals going through uncommon cancers are simply as in want of higher prevention, therapies, and cures as these going through widespread cancers.

For uncommon most cancers assets or help, go to NORD, the National Cancer Institute or Cancer.Net. Contemplate becoming a member of the motion on February 28 by sharing your expertise with uncommon illnesses on social media utilizing the hashtag #RareDiseaseDay. As consciousness of uncommon illnesses—like uncommon most cancers—will increase, so do enhancements in affected person care and outcomes.


Katie Heller, MA, is a visitor author who works in advertising and medical schooling at ECOG-ACRIN Most cancers Analysis Group. Beforehand, she held roles on the American Society of Medical Oncology and their basis, Conquer Most cancers. She has practically a decade of expertise in oncology and well being care communications. Katie acquired a Bachelor’s Diploma in English from Loyola College Maryland and a Grasp’s Diploma in Media, Tradition, and Communication from New York College.